APO Research
Talk to an analyst

APO RESEARCH · REPORT

Sacral Neuromodulation Device

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Sacral Neuromodulation Device Market Outlook and Growth Opportunities 2026

5 July 2026190 pages

Choose your research edition.

Industry ResearchSacral Neuromodulation Device Industry Research Report 2026116 pages · $2,950 USDIndustry Growth & TrendsGlobal Sacral Neuromodulation Device Industry Growth and Trends Forecast to 203296 pages · $3,450 USDMarket StructureGlobal Sacral Neuromodulation Device Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032188 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Sacral Neuromodulation Device Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Sacral Neuromodulation Device Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Sacral Neuromodulation Device market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Sacral Neuromodulation Device is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Sacral Neuromodulation Device is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Sacral Neuromodulation Device is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Sacral Neuromodulation Device market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Sacral Neuromodulation Device market include Axonics (Boston Scientific), Neuspera, General Stim (Nurotron), Medtronic and PINS Medical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Sacral Neuromodulation Device market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Sacral Neuromodulation Device and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Sacral Neuromodulation Device sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Sacral Neuromodulation Device market size, projected growth trends, production technologies, key applications, and end-use industries.

Sacral Neuromodulation Device Segment by Company

Axonics (Boston Scientific)

Neuspera

General Stim (Nurotron)

Medtronic

PINS Medical

Sacral Neuromodulation Device Segment by Type

Rechargeable

Recharge-free

Sacral Neuromodulation Device Segment by Application

Hospitals

ASCs

Sacral Neuromodulation Device Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Sacral Neuromodulation Device status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Sacral Neuromodulation Device market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Sacral Neuromodulation Device significant trends, drivers, influence factors in global and regions.

6. To analyze Sacral Neuromodulation Device competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Sacral Neuromodulation Device market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Sacral Neuromodulation Device and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Sacral Neuromodulation Device.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Sacral Neuromodulation Device market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Sacral Neuromodulation Device industry.

Chapter 3: Detailed analysis of Sacral Neuromodulation Device manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Sacral Neuromodulation Device in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Sacral Neuromodulation Device in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Sacral Neuromodulation Device Industry Trends Table 2. Sacral Neuromodulation Device Industry Drivers Table 3. Sacral Neuromodulation Device Industry Opportunities and Challenges Table 4. Sacral Neuromodulation Device Industry Restraints Table 5. Global Sacral Neuromodulation Device Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Sacral Neuromodulation Device Revenue Share by Company (2021-2026) Table 7. Global Sacral Neuromodulation Device Sales Volume by Company (units) & (2021-2026) Table 8. Global Sacral Neuromodulation Device Sales Volume Share by Company (2021-2026) Table 9. Global Sacral Neuromodulation Device Average Price (USD/unit) of Company (2021-2026) Table 10. Global Sacral Neuromodulation Device Company Ranking, (2024-2026) & (USD Million) Table 11. Global Sacral Neuromodulation Device Key Company Manufacturing Base & Headquarters Table 12. Global Sacral Neuromodulation Device Company, Product Type & Application Table 13. Global Sacral Neuromodulation Device Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Sacral Neuromodulation Device by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Rechargeable Table 18. Significant Companies of Recharge-free Table 19. Global Sacral Neuromodulation Device Sales Volume by Type 2021 VS 2025 VS 2032 (units) Table 20. Global Sacral Neuromodulation Device Sales Volume by Type (2021-2026) & (units) Table 21. Global Sacral Neuromodulation Device Sales Volume by Type (2027-2032) & (units) Table 22. Global Sacral Neuromodulation Device Sales Volume Share by Type (2021-2026) Table 23. Global Sacral Neuromodulation Device Sales Volume Share by Type (2027-2032) Table 24. Global Sacral Neuromodulation Device Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Sacral Neuromodulation Device Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Sacral Neuromodulation Device Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Sacral Neuromodulation Device Sales Value Share by Type (2021-2026) Table 28. Global Sacral Neuromodulation Device Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Hospitals Table 30. Significant Companies of ASCs Table 31. Global Sacral Neuromodulation Device Sales Volume by Application 2021 VS 2025 VS 2032 (units) Table 32. Global Sacral Neuromodulation Device Sales Volume by Application (2021-2026) & (units) Table 33. Global Sacral Neuromodulation Device Sales Volume by Application (2027-2032) & (units) Table 34. Global Sacral Neuromodulation Device Sales Volume Share by Application (2021-2026) Table 35. Global Sacral Neuromodulation Device Sales Volume Share by Application (2027-2032) Table 36. Global Sacral Neuromodulation Device Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Sacral Neuromodulation Device Sales Value by Application (2021-2026) & (US$ Million) Table 38. Global Sacral Neuromodulation Device Sales Value by Application (2027-2032) & (US$ Million) Table 39. Global Sacral Neuromodulation Device Sales Value Share by Application (2021-2026) Table 40. Global Sacral Neuromodulation Device Sales Value Share by Application (2027-2032) Table 41. Global Sacral Neuromodulation Device Sales by Region: 2021 VS 2025 VS 2032 (units) Table 42. Global Sacral Neuromodulation Device Sales by Region (2021-2026) & (units) Table 43. Global Sacral Neuromodulation Device Sales Market Share by Region (2021-2026) Table 44. Global Sacral Neuromodulation Device Sales by Region (2027-2032) & (units) Table 45. Global Sacral Neuromodulation Device Sales Market Share by Region (2027-2032) Table 46. Global Sacral Neuromodulation Device Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Sacral Neuromodulation Device Sales Value by Region (2021-2026) & (US$ Million) Table 48. Global Sacral Neuromodulation Device Sales Value Share by Region (2021-2026) Table 49. Global Sacral Neuromodulation Device Sales Value by Region (2027-2032) & (US$ Million) Table 50. Global Sacral Neuromodulation Device Sales Value Share by Region (2027-2032) Table 51. Global Sacral Neuromodulation Device Market Average Price (USD/unit) by Region (2021-2026) Table 52. Global Sacral Neuromodulation Device Market Average Price (USD/unit) by Region (2027-2032) Table 53. Global Sacral Neuromodulation Device Sales by Country: 2021 VS 2025 VS 2032 (units) Table 54. Global Sacral Neuromodulation Device Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 55. Global Sacral Neuromodulation Device Sales by Country (2021-2026) & (units) Table 56. Global Sacral Neuromodulation Device Sales Market Share by Country (2021-2026) Table 57. Global Sacral Neuromodulation Device Sales by Country (2027-2032) & (units) Table 58. Global Sacral Neuromodulation Device Sales Market Share by Country (2027-2032) Table 59. Global Sacral Neuromodulation Device Sales Value by Country (2021-2026) & (US$ Million) Table 60. Global Sacral Neuromodulation Device Sales Value Market Share by Country (2021-2026) Table 61. Global Sacral Neuromodulation Device Sales Value by Country (2027-2032) & (US$ Million) Table 62. Global Sacral Neuromodulation Device Sales Value Market Share by Country (2027-2032) Table 63. Axonics (Boston Scientific) Company Information Table 64. Axonics (Boston Scientific) Business Overview Table 65. Axonics (Boston Scientific) Sacral Neuromodulation Device Sales (units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 66. Axonics (Boston Scientific) Sacral Neuromodulation Device Product Portfolio Table 67. Axonics (Boston Scientific) Recent Development Table 68. Neuspera Company Information Table 69. Neuspera Business Overview Table 70. Neuspera Sacral Neuromodulation Device Sales (units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 71. Neuspera Sacral Neuromodulation Device Product Portfolio Table 72. Neuspera Recent Development Table 73. General Stim (Nurotron) Company Information Table 74. General Stim (Nurotron) Business Overview Table 75. General Stim (Nurotron) Sacral Neuromodulation Device Sales (units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 76. General Stim (Nurotron) Sacral Neuromodulation Device Product Portfolio Table 77. General Stim (Nurotron) Recent Development Table 78. Medtronic Company Information Table 79. Medtronic Business Overview Table 80. Medtronic Sacral Neuromodulation Device Sales (units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 81. Medtronic Sacral Neuromodulation Device Product Portfolio Table 82. Medtronic Recent Development Table 83. PINS Medical Company Information Table 84. PINS Medical Business Overview Table 85. PINS Medical Sacral Neuromodulation Device Sales (units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 86. PINS Medical Sacral Neuromodulation Device Product Portfolio Table 87. PINS Medical Recent Development Table 88. Key Raw Materials Table 89. Raw Materials Key Suppliers Table 90. Sacral Neuromodulation Device Distributors List Table 91. Sacral Neuromodulation Device Customers List Table 92. Research Programs/Design for This Report Table 93. Authors List of This Report Table 94. Secondary Sources Table 95. Primary Sources List of Figures Figure 1. Sacral Neuromodulation Device Product Image Figure 2. Global Sacral Neuromodulation Device Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Sacral Neuromodulation Device Sales Value (2021-2032) & (US$ Million) Figure 4. Global Sacral Neuromodulation Device Sales (2021-2032) & (units) Figure 5. Global Sacral Neuromodulation Device Sales Average Price (USD/unit) & (2021-2032) Figure 6. Global Sacral Neuromodulation Device Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Rechargeable Image Figure 10. Recharge-free Image Figure 11. Global Sacral Neuromodulation Device Sales Volume by Type (2021 VS 2025 VS 2032) & (units) Figure 12. Global Sacral Neuromodulation Device Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Sacral Neuromodulation Device Sales Volume Share by Type (2021-2032) Figure 14. Global Sacral Neuromodulation Device Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Sacral Neuromodulation Device Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Sacral Neuromodulation Device Sales Value Share by Type (2021-2032) Figure 17. Hospitals Image Figure 18. ASCs Image Figure 19. Global Sacral Neuromodulation Device Sales Volume by Application (2021 VS 2025 VS 2032) & (units) Figure 20. Global Sacral Neuromodulation Device Sales Volume Share 2021 VS 2025 VS 2032 Figure 21. Global Sacral Neuromodulation Device Sales Volume Share by Application (2021-2032) Figure 22. Global Sacral Neuromodulation Device Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Sacral Neuromodulation Device Sales Value Share 2021 VS 2025 VS 2032 Figure 24. Global Sacral Neuromodulation Device Sales Value Share by Application (2021-2032) Figure 25. Global Sacral Neuromodulation Device Sales by Region: 2021 VS 2025 VS 2032 (units) Figure 26. Global Sacral Neuromodulation Device Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 27. Global Sacral Neuromodulation Device Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 28. Global Sacral Neuromodulation Device Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 29. North America Sacral Neuromodulation Device Sales Value (2021-2032) & (US$ Million) Figure 30. North America Sacral Neuromodulation Device Sales Value Share by Country (%), 2025 VS 2032 Figure 31. Europe Sacral Neuromodulation Device Sales Value (2021-2032) & (US$ Million) Figure 32. Europe Sacral Neuromodulation Device Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Asia-Pacific Sacral Neuromodulation Device Sales Value (2021-2032) & (US$ Million) Figure 34. Asia-Pacific Sacral Neuromodulation Device Sales Value Share by Country (%), 2025 VS 2032 Figure 35. South America Sacral Neuromodulation Device Sales Value (2021-2032) & (US$ Million) Figure 36. South America Sacral Neuromodulation Device Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Middle East & Africa Sacral Neuromodulation Device Sales Value (2021-2032) & (US$ Million) Figure 38. Middle East & Africa Sacral Neuromodulation Device Sales Value Share by Country (%), 2025 VS 2032 Figure 39. USA Sacral Neuromodulation Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. USA Sacral Neuromodulation Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. USA Sacral Neuromodulation Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. Canada Sacral Neuromodulation Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. Canada Sacral Neuromodulation Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. Canada Sacral Neuromodulation Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Mexico Sacral Neuromodulation Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Mexico Sacral Neuromodulation Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Mexico Sacral Neuromodulation Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Germany Sacral Neuromodulation Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Germany Sacral Neuromodulation Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Germany Sacral Neuromodulation Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. France Sacral Neuromodulation Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. France Sacral Neuromodulation Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. France Sacral Neuromodulation Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. U.K. Sacral Neuromodulation Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. U.K. Sacral Neuromodulation Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. U.K. Sacral Neuromodulation Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Italy Sacral Neuromodulation Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Italy Sacral Neuromodulation Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Italy Sacral Neuromodulation Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Spain Sacral Neuromodulation Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Spain Sacral Neuromodulation Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Spain Sacral Neuromodulation Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Russia Sacral Neuromodulation Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Russia Sacral Neuromodulation Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Russia Sacral Neuromodulation Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Netherlands Sacral Neuromodulation Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Netherlands Sacral Neuromodulation Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Netherlands Sacral Neuromodulation Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Nordic Countries Sacral Neuromodulation Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Nordic Countries Sacral Neuromodulation Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Nordic Countries Sacral Neuromodulation Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. China Sacral Neuromodulation Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. China Sacral Neuromodulation Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. China Sacral Neuromodulation Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Japan Sacral Neuromodulation Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Japan Sacral Neuromodulation Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Japan Sacral Neuromodulation Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. South Korea Sacral Neuromodulation Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. South Korea Sacral Neuromodulation Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. South Korea Sacral Neuromodulation Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. India Sacral Neuromodulation Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. India Sacral Neuromodulation Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. India Sacral Neuromodulation Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Australia Sacral Neuromodulation Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Australia Sacral Neuromodulation Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Australia Sacral Neuromodulation Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Southeast Asia Sacral Neuromodulation Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Southeast Asia Sacral Neuromodulation Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Southeast Asia Sacral Neuromodulation Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Brazil Sacral Neuromodulation Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Brazil Sacral Neuromodulation Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Brazil Sacral Neuromodulation Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Argentina Sacral Neuromodulation Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Argentina Sacral Neuromodulation Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Argentina Sacral Neuromodulation Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Chile Sacral Neuromodulation Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Chile Sacral Neuromodulation Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Chile Sacral Neuromodulation Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Colombia Sacral Neuromodulation Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Colombia Sacral Neuromodulation Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Colombia Sacral Neuromodulation Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Peru Sacral Neuromodulation Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Peru Sacral Neuromodulation Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Peru Sacral Neuromodulation Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Saudi Arabia Sacral Neuromodulation Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Saudi Arabia Sacral Neuromodulation Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Sacral Neuromodulation Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Israel Sacral Neuromodulation Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Israel Arabia Sacral Neuromodulation Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Israel Arabia Sacral Neuromodulation Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. UAE Sacral Neuromodulation Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. UAE Sacral Neuromodulation Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. UAE Sacral Neuromodulation Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Turkey Sacral Neuromodulation Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Turkey Sacral Neuromodulation Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Turkey Sacral Neuromodulation Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Iran Sacral Neuromodulation Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Iran Sacral Neuromodulation Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Iran Sacral Neuromodulation Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Egypt Sacral Neuromodulation Device Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Egypt Sacral Neuromodulation Device Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Egypt Sacral Neuromodulation Device Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Sacral Neuromodulation Device Value Chain Figure 124. Manufacturing Cost Structure Figure 125. Sacral Neuromodulation Device Sales Mode & Process Figure 126. Direct Comparison with Distribution Share Figure 127. Distributors Profiles Figure 128. Years Considered Figure 129. Research Process Figure 130. Key Executives Interviewed

Scope & coverage.

Types
  • Rechargeable
  • Recharge-free
Applications
  • Hospitals
  • ASCs
Companies covered
  • Axonics (Boston Scientific)
  • Neuspera
  • General Stim (Nurotron)
  • Medtronic
  • PINS Medical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Sacral Neuromodulation Device Sales Value (2021-2032)
  4. 1.2.2 Global Sacral Neuromodulation Device Sales Volume (2021-2032)
  5. 1.2.3 Global Sacral Neuromodulation Device Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Sacral Neuromodulation Device Market Dynamics
  1. 2.1 Sacral Neuromodulation Device Industry Trends
  2. 2.2 Sacral Neuromodulation Device Industry Drivers
  3. 2.3 Sacral Neuromodulation Device Industry Opportunities and Challenges
  4. 2.4 Sacral Neuromodulation Device Industry Restraints
3 Sacral Neuromodulation Device Market by Company
  1. 3.1 Global Sacral Neuromodulation Device Company Revenue Ranking in 2025
  2. 3.2 Global Sacral Neuromodulation Device Revenue by Company (2021-2026)
  3. 3.3 Global Sacral Neuromodulation Device Sales Volume by Company (2021-2026)
  4. 3.4 Global Sacral Neuromodulation Device Average Price by Company (2021-2026)
  5. 3.5 Global Sacral Neuromodulation Device Company Ranking (2024-2026)
  6. 3.6 Global Sacral Neuromodulation Device Company Manufacturing Base and Headquarters
  7. 3.7 Global Sacral Neuromodulation Device Company Product Type and Application
  8. 3.8 Global Sacral Neuromodulation Device Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Sacral Neuromodulation Device Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Sacral Neuromodulation Device Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Sacral Neuromodulation Device Market by Type
  1. 4.1 Sacral Neuromodulation Device Type Introduction
  2. 4.1.1 Rechargeable
  3. 4.1.2 Recharge-free
  4. 4.2 Global Sacral Neuromodulation Device Sales Volume by Type
  5. 4.2.1 Global Sacral Neuromodulation Device Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Sacral Neuromodulation Device Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Sacral Neuromodulation Device Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Sacral Neuromodulation Device Sales Value by Type
  9. 4.3.1 Global Sacral Neuromodulation Device Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Sacral Neuromodulation Device Sales Value by Type (2021-2032)
  11. 4.3.3 Global Sacral Neuromodulation Device Sales Value Share by Type (2021-2032)
5 Sacral Neuromodulation Device Market by Application
  1. 5.1 Sacral Neuromodulation Device Application Introduction
  2. 5.1.1 Hospitals
  3. 5.1.2 ASCs
  4. 5.2 Global Sacral Neuromodulation Device Sales Volume by Application
  5. 5.2.1 Global Sacral Neuromodulation Device Sales Volume by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Sacral Neuromodulation Device Sales Volume by Application (2021-2032)
  7. 5.2.3 Global Sacral Neuromodulation Device Sales Volume Share by Application (2021-2032)
  8. 5.3 Global Sacral Neuromodulation Device Sales Value by Application
  9. 5.3.1 Global Sacral Neuromodulation Device Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Sacral Neuromodulation Device Sales Value by Application (2021-2032)
  11. 5.3.3 Global Sacral Neuromodulation Device Sales Value Share by Application (2021-2032)
6 Sacral Neuromodulation Device Regional Sales and Value Analysis
  1. 6.1 Global Sacral Neuromodulation Device Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Sacral Neuromodulation Device Sales by Region (2021-2032)
  3. 6.2.1 Global Sacral Neuromodulation Device Sales by Region: 2021-2026
  4. 6.2.2 Global Sacral Neuromodulation Device Sales by Region (2027-2032)
  5. 6.3 Global Sacral Neuromodulation Device Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Sacral Neuromodulation Device Sales Value by Region (2021-2032)
  7. 6.4.1 Global Sacral Neuromodulation Device Sales Value by Region: 2021-2026
  8. 6.4.2 Global Sacral Neuromodulation Device Sales Value by Region (2027-2032)
  9. 6.5 Global Sacral Neuromodulation Device Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Sacral Neuromodulation Device Sales Value (2021-2032)
  12. 6.6.2 North America Sacral Neuromodulation Device Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Sacral Neuromodulation Device Sales Value (2021-2032)
  15. 6.7.2 Europe Sacral Neuromodulation Device Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Sacral Neuromodulation Device Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Sacral Neuromodulation Device Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Sacral Neuromodulation Device Sales Value (2021-2032)
  21. 6.9.2 South America Sacral Neuromodulation Device Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Sacral Neuromodulation Device Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Sacral Neuromodulation Device Sales Value Share by Country, 2025 VS 2032
7 Sacral Neuromodulation Device Country-level Sales and Value Analysis
  1. 7.1 Global Sacral Neuromodulation Device Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Sacral Neuromodulation Device Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Sacral Neuromodulation Device Sales by Country (2021-2032)
  4. 7.3.1 Global Sacral Neuromodulation Device Sales by Country (2021-2026)
  5. 7.3.2 Global Sacral Neuromodulation Device Sales by Country (2027-2032)
  6. 7.4 Global Sacral Neuromodulation Device Sales Value by Country (2021-2032)
  7. 7.4.1 Global Sacral Neuromodulation Device Sales Value by Country (2021-2026)
  8. 7.4.2 Global Sacral Neuromodulation Device Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Sacral Neuromodulation Device Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Sacral Neuromodulation Device Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Sacral Neuromodulation Device Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Sacral Neuromodulation Device Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Sacral Neuromodulation Device Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Sacral Neuromodulation Device Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Sacral Neuromodulation Device Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Sacral Neuromodulation Device Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Sacral Neuromodulation Device Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Sacral Neuromodulation Device Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Sacral Neuromodulation Device Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Sacral Neuromodulation Device Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Sacral Neuromodulation Device Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Sacral Neuromodulation Device Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Sacral Neuromodulation Device Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Sacral Neuromodulation Device Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Sacral Neuromodulation Device Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Sacral Neuromodulation Device Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Sacral Neuromodulation Device Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Sacral Neuromodulation Device Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Sacral Neuromodulation Device Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Sacral Neuromodulation Device Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Sacral Neuromodulation Device Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Sacral Neuromodulation Device Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Sacral Neuromodulation Device Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Sacral Neuromodulation Device Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Sacral Neuromodulation Device Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Sacral Neuromodulation Device Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Sacral Neuromodulation Device Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Sacral Neuromodulation Device Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Sacral Neuromodulation Device Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Sacral Neuromodulation Device Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Sacral Neuromodulation Device Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Sacral Neuromodulation Device Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Sacral Neuromodulation Device Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Sacral Neuromodulation Device Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Sacral Neuromodulation Device Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Sacral Neuromodulation Device Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Sacral Neuromodulation Device Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Sacral Neuromodulation Device Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Sacral Neuromodulation Device Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Sacral Neuromodulation Device Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Sacral Neuromodulation Device Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Sacral Neuromodulation Device Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Sacral Neuromodulation Device Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Sacral Neuromodulation Device Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Sacral Neuromodulation Device Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Sacral Neuromodulation Device Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Sacral Neuromodulation Device Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Sacral Neuromodulation Device Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Sacral Neuromodulation Device Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Sacral Neuromodulation Device Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Sacral Neuromodulation Device Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Sacral Neuromodulation Device Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Sacral Neuromodulation Device Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Sacral Neuromodulation Device Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Sacral Neuromodulation Device Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Sacral Neuromodulation Device Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Sacral Neuromodulation Device Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Sacral Neuromodulation Device Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Sacral Neuromodulation Device Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Sacral Neuromodulation Device Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Sacral Neuromodulation Device Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Sacral Neuromodulation Device Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Sacral Neuromodulation Device Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Sacral Neuromodulation Device Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Sacral Neuromodulation Device Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Sacral Neuromodulation Device Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Sacral Neuromodulation Device Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Sacral Neuromodulation Device Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Sacral Neuromodulation Device Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Sacral Neuromodulation Device Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Sacral Neuromodulation Device Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Sacral Neuromodulation Device Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Sacral Neuromodulation Device Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Sacral Neuromodulation Device Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Sacral Neuromodulation Device Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Sacral Neuromodulation Device Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Sacral Neuromodulation Device Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Sacral Neuromodulation Device Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Sacral Neuromodulation Device Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Sacral Neuromodulation Device Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Sacral Neuromodulation Device Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Sacral Neuromodulation Device Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Axonics (Boston Scientific)
  2. 8.1.1 Axonics (Boston Scientific) Company Information
  3. 8.1.2 Axonics (Boston Scientific) Business Overview
  4. 8.1.3 Axonics (Boston Scientific) Sacral Neuromodulation Device Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Axonics (Boston Scientific) Sacral Neuromodulation Device Product Portfolio
  6. 8.1.5 Axonics (Boston Scientific) Recent Developments
  7. 8.2 Neuspera
  8. 8.2.1 Neuspera Company Information
  9. 8.2.2 Neuspera Business Overview
  10. 8.2.3 Neuspera Sacral Neuromodulation Device Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Neuspera Sacral Neuromodulation Device Product Portfolio
  12. 8.2.5 Neuspera Recent Developments
  13. 8.3 General Stim (Nurotron)
  14. 8.3.1 General Stim (Nurotron) Company Information
  15. 8.3.2 General Stim (Nurotron) Business Overview
  16. 8.3.3 General Stim (Nurotron) Sacral Neuromodulation Device Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 General Stim (Nurotron) Sacral Neuromodulation Device Product Portfolio
  18. 8.3.5 General Stim (Nurotron) Recent Developments
  19. 8.4 Medtronic
  20. 8.4.1 Medtronic Company Information
  21. 8.4.2 Medtronic Business Overview
  22. 8.4.3 Medtronic Sacral Neuromodulation Device Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Medtronic Sacral Neuromodulation Device Product Portfolio
  24. 8.4.5 Medtronic Recent Developments
  25. 8.5 PINS Medical
  26. 8.5.1 PINS Medical Company Information
  27. 8.5.2 PINS Medical Business Overview
  28. 8.5.3 PINS Medical Sacral Neuromodulation Device Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 PINS Medical Sacral Neuromodulation Device Product Portfolio
  30. 8.5.5 PINS Medical Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Sacral Neuromodulation Device Value Chain Analysis
  2. 9.1.1 Sacral Neuromodulation Device Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Sacral Neuromodulation Device Sales Mode & Process
  6. 9.2 Sacral Neuromodulation Device Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Sacral Neuromodulation Device Distributors
  9. 9.2.3 Sacral Neuromodulation Device Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst